Skip to main content
Premium Trial:

Request an Annual Quote

David Altshuler

David Altshuler is leaving the Broad Institute of Harvard University and the Massachusetts Institute of Technology to join Vertex Pharmaceuticals as executive VP, global research and chief scientific officer. Altshuler was one of the four founding members of the Broad and has served as deputy director and chief academic officer since 2009. He also is currently a professor of genetics and medicine at Harvard Medical School and an adjunct professor of biology at MIT.

Altshuler has resigned from his position as a Vertex director and will begin his new role at the firm in early 2015.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.